Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai

National Medical Journal of China

Volumn 85, Issue 43, 2005, Pages 3030-3034

  Song, Chuan Gui ^a   Hu, Zhen ^a   Yuan, Wen Tao ^a   Di, Gen Hong ^a   Shen, Zhen Zhou ^a   Huang, Wei ^a   Shao, Zhi Min ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast neoplasms; Gene, BRCA1; Mutation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER SCREENING; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; EXON; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTRON; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PREVALENCE; SEQUENCE ANALYSIS;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHINA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INCIDENCE; MUTATION; POLYMERASE CHAIN REACTION;

EID: 31344474363     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Krainer M, Silva-Arrieta S, FitzGerald MG, et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Eng J Med, 1997, 336:1416-1421.
2. Loman N, Johannsson O, Kristoffersson U, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst, 2001, 93:1215-1223.
3. Ding XM, Lang JH. BRCA1 gene mutations in early-onset breast cancer. Natl Med J China, 2000, 80: 111-113.
4. Zhou YZ, Sun Q, Lin SQ, et al. Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people. Natl Med J China, 2004, 84:294-298.
5. Gross E, Arnold N, Pfeifer K, et al. Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat, 2000, 16: 345-353.
6. Arnold N, Gross E, Schwarz-Boeger U, et al. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat, 1999, 14: 333-339.
7. Meyer P, Voigtlaender T, Bartram CR, et al. Twenty-three novel BRCA1 and BRCA2 Sequence alterations in breast and/or ovarian cancer families in southern Germany. Hum Mutat, 2003, 22:259.
8. Breast Cancer Information Core (BIC) database [http://www.nhgri.nih.gov/Intramural_research/lab_transfer/Bic/]. 2004.
9. Tang NL, Pang CP, Yeo W, et al. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst, 1999, 91: 882-885.
10. Hu Z, Wu J, Liu CH, et al. The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat, 2003, 22:104.
11. Durocher F, Shattuck-Eidens D, McClure M, et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet, 1996,5: 835-842.
12. Wagner TM, Hirtenlehner K, Shen P, et al. Global sequence diversity of BRCA2: analysis of 71breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet, 1999, 8:413-423.
13. Suter NM, Ray RM, Hu YW, et al. BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev, 2004, 13:181-189.
14. Plaschke J, Commer T, Jacobi C, et al. BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease. J Med Genet, 2000, 37: E17.